Recurrence | ||||
---|---|---|---|---|
Variable | Yes (n = 36) | No (n = 35) | p-value | |
Age (mean ± SD) | 48.8 ± 10.03 | 45.8 ± 9.22 | NS** | |
Sex | Male | 22(46.8%) | 25 (53.2%) | NS* |
Female | 14 (58.3%) | 10 (41.7%) | ||
Bcl-XL expression | -ve | 10 (23.8%) | 32 (76.2%) | 0.000* |
+ve | 26 (89.7%) | 3(10.3%) | ||
Histo-pathologic Grade | Grade 1 | 6 (24%) | 19 (76%) | 0.002* |
Grade 2 | 19(59.4%) | 13(40.6%) | ||
Grade 3 | 11(78.6%) | 3(21.4%) | ||
Radiotherapy | Done | 15 (39.5%) | 23 (60.5%) | 0.04* |
Not Done | 21 (63.6%) | 12 (36.4%) | ||
Stage | Stage 1-2 | 31(50.8%) | 30(49.2%) | NS* |
Stage 3 | 5 (50%) | 5(50%) | ||
Tumor Size | Small < 3 cm | 9(39.1%) | 14(60.9%) | NS* |
Large > 3 cm | 27 (56.2%) | 21(43.8%) |